Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
It works as a great energy booster
June 2024: Structure Therapeutics reported positive Phase IIa obesity data for GSBR-1290, an oral non-peptide small-molecule GLP-1 receptor agonist, achieving 6.2% placebo-adjusted mean weight loss at 12 weeks
But unlike typical sugar, its absorbed but not metabolizedmeaning it contributes virtually zero calories and doesnt spike blood glucose or insulin levels
Prognostic value of metabolic imaging data of (11)C-choline PET/CT in patients undergoing hepatectomy for hepatocellular carcinoma
US$ 28.91
US$ 29.79
US$ 29.83
US$ 21.37
US$ 21.32
US$ 22.27
US$ 24.40
US$ 21.39
